Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
2.830 CAD | +2.54% | +2.17% | -17.73% |
Sales 2023 * | 120 M 89.14 M | Sales 2024 * | 147 M 109 M | Capitalization | 1,079 M 798 M |
---|---|---|---|---|---|
Net income 2023 * | -49.00 M -36.27 M | Net income 2024 * | -13.00 M -9.62 M | EV / Sales 2023 * | -0,64x |
Net cash position 2023 * | 1,156 M 856 M | Net cash position 2024 * | 1,174 M 869 M | EV / Sales 2024 * | -0,65x |
P/E ratio 2023 * | -21,5x | P/E ratio 2024 * | -61,7x | Employees | 447 |
Yield 2023 * | - | Yield 2024 * | - | Free-Float | 52.47% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
1 day | +2.54% | ||
1 week | +2.17% | ||
Current month | +2.54% | ||
1 month | +11.86% | ||
3 months | +5.99% | ||
6 months | +19.41% | ||
Current year | -17.73% |
1 week
2.58
2.83

1 month
2.51
2.90

Current year
2.15
3.57

1 year
2.15
4.88

3 years
2.15
20.08

5 years
2.15
32.95

10 years
0.14
32.95

Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 36 | 2015 | |
James Holm
DFI | Director of Finance/CFO | 40 | Nov. 13 |
Arye Weigensberg
CTO | Chief Tech/Sci/R&D Officer | 40 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 47 | 2021 | |
James D. Rudyk
BRD | Director/Board Member | 56 | 2018 |
Jason Adler
BRD | Director/Board Member | 51 | 2016 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
12.68% | 52 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-01 | 2.830 | +2.54% | 149,893 |
23-11-30 | 2.760 | +3.37% | 277,382 |
23-11-29 | 2.670 | +1.14% | 65,055 |
23-11-28 | 2.640 | -0.75% | 107,709 |
23-11-27 | 2.660 | -3.97% | 60,081 |
Delayed Quote Toronto Stock Exchange, December 01, 2023 at 04:00 pm EST
More quotes
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Companyâs segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Companyâs international brand portfolio includes Spinach, PEACE NATURALS, Lord Jones, Happy Dance and PEACE+. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Companyâs subsidiaries include Cronos Israel G.S. Cultivation Ltd., Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd., and Cronos Israel G.S. Pharmacy Ltd.
Sector
Pharmaceuticals
Calendar
2024-02-26
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
D-
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
2.830CAD
Average target price
3.378CAD
Spread / Average Target
+19.35%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.73% | 799 M $ | |
-16.96% | 5 823 M $ | |
+25.11% | 4 594 M $ | |
+82.30% | 3 269 M $ | |
+42.10% | 3 200 M $ | |
-15.14% | 2 763 M $ | |
+13.01% | 2 156 M $ | |
-20.42% | 1 902 M $ | |
+4.60% | 1 767 M $ | |
+1.23% | 1 603 M $ |